نتائج البحث - "Isabell Bernlochner"

1

Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention

المؤلفون: Heribert Schunkert, Lisena Cala, Dirk Sibbing, Siegmund Braun, Petra Hoppmann, Martin Orban, Adnan Kastrati, Isabell Bernlochner, Tanja Morath, Katharina Mayer, Stefanie Schulz, Karl-Ludwig Laugwitz

المصدر: Journal of the American College of Cardiology. 64(9):863-871

مصطلحات موضوعية: Aspirin, medicine.medical_specialty, Treatment regimen, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, Platelet inhibition, Platelet reactivity, Internal medicine, Conventional PCI, Antithrombotic, medicine, Cardiology, Prognostic biomarker, cardiovascular diseases, business, Cardiology and Cardiovascular Medicine, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c7e5bad0534442a16603faddc8f5a54Test

2

Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention

المؤلفون: Bernhard Haller, Dirk Sibbing, Adnan Kastrati, Isabell Bernlochner, Stefanie Schüpke, Heribert Schunkert, Isabel Wustrow, Aida Anetsberger, Karl-Ludwig Laugwitz, Nikolaus Sarafoff, Tareq Ibrahim, Lisa Rössner

المصدر: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 92(7)

مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, medicine.medical_treatment, Administration, Oral, Hemorrhage, Coronary Artery Disease, 030204 cardiovascular system & hematology, Risk Assessment, Coronary artery disease, 03 medical and health sciences, 0302 clinical medicine, Percutaneous Coronary Intervention, Fibrinolytic Agents, Risk Factors, Internal medicine, Germany, Antithrombotic, Absorbable Implants, Clinical endpoint, Medicine, Humans, Radiology, Nuclear Medicine and imaging, 030212 general & internal medicine, Registries, Aged, Aged, 80 and over, Aspirin, business.industry, Hazard ratio, Percutaneous coronary intervention, Anticoagulants, Drug-Eluting Stents, General Medicine, Thrombolysis, medicine.disease, Treatment Outcome, Conventional PCI, Cardiology, Drug Therapy, Combination, Female, Cardiology and Cardiovascular Medicine, business, TIMI, Platelet Aggregation Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df3c758eb7d4fa7dcc379c1ae606688aTest
https://pubmed.ncbi.nlm.nih.gov/30770673Test

3

Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents

المصدر: Harada, Y, Michel, J, Lohaus, R, Mayer, K, Emmer, R, Lahmann, A L, Colleran, R, Giacoppo, D, Wolk, A, Ten Berg, J M, Neumann, F-J, Han, Y, Adriaenssens, T, Tölg, R, Seyfarth, M, Maeng, M, Zrenner, B, Jacobshagen, C, Wöhrle, J, Kufner, S, Morath, T, Ibrahim, T, Bernlochner, I, Fischer, M, Schunkert, H, Laugwitz, K-L, Mehilli, J, Byrne, R A, Kastrati, A & Schulz-Schüpke, S 2017, ' Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents ', Thrombosis and Haemostasis, vol. 117, no. 10, pp. 1989-1999 . https://doi.org/10.1160/TH17-02-0101Test

مصطلحات موضوعية: Male, Time Factors, medicine.medical_treatment, Placebo-controlled study, Myocardial Infarction, Coronary Disease, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, 0302 clinical medicine, Risk Factors, 030212 general & internal medicine, media_common, Drug-Eluting Stents, Hematology, Clopidogrel, Stroke, Treatment Outcome, Cohort, Drug Therapy, Combination, Female, medicine.drug, Drug, medicine.medical_specialty, Decision tool, Ticlopidine, animal structures, media_common.quotation_subject, Clinical Decision-Making, Hemorrhage, Prosthesis Design, Drug Administration Schedule, Decision Support Techniques, 03 medical and health sciences, Percutaneous Coronary Intervention, Double-Blind Method, Predictive Value of Tests, medicine, Journal Article, Humans, In patient, Derivation, Aged, Proportional Hazards Models, Aspirin, business.industry, Coronary Thrombosis, Percutaneous coronary intervention, Reproducibility of Results, Surgery, business, Platelet Aggregation Inhibitors